| 1 |
中华人民共和国国家卫生健康委员会. 新生儿持续肺动脉高压诊疗指南(2025年版)[J]. 中国合理用药探索,2025, 22(9): 165-169.
|
| 2 |
杨芙蓉,谢万木.《慢性血栓栓塞性肺动脉高压诊断与治疗指南(2024版)》解读[J]. 协和医学杂志,2025, 16(3): 673-679.
|
| 3 |
Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review[J]. JAMA, 2022, 327(14): 1379-1391.
|
| 4 |
徐婉婷,江晓琴,朱涛. 肺动脉高压的治疗进展[J].中国呼吸与危重监护杂志,2024, 23(4): 287-292.
|
| 5 |
杨芙蓉,谢万木.《慢性血栓栓塞性肺动脉高压诊断与治疗指南(2024版)》解读[J]. 协和医学杂志,2025, 16(3): 673-679.
|
| 6 |
Mocumbi A, Humbert M, Saxena A, et al. Pulmonary hypertension[J]. Nat Rev Dis Primers, 2024, 10(1): 1.
|
| 7 |
陈睿迪,王炜,张若旸. 巨噬细胞在间质性肺疾病相关肺动脉高压中的作用[J]. 微生物学免疫学进展,2025, 53(04): 87-93.
|
| 8 |
张若柳,方学升,席照青,等. 激活巨噬细胞Toll样受体7对肺动脉高压中肺动脉平滑肌增殖与迁移的影响[J]. 中国医药导报,2025, 22(2): 1-6,24.
|
| 9 |
陈倩冰,李逸轩,刘怡曼,等. 肺动脉高压血管重塑过程中的巨噬细胞核心作用机制研究探讨[J]. 天津中医药,2024, 41(10): 1325-1334.
|
| 10 |
Kovacs G, Bartolome S, Denton CP, et al. Definition, classification and diagnosis of pulmonary hypertension[J]. Eur Respir J, 2024, 64(4): 2401324.
|
| 11 |
Sahay S, Chakinala MM, Kim NH, et al. Contemporary treatment of pulmonary arterial hypertension: A U.S. Perspective[J]. Am J Respir Crit Care Med, 2024, 210(5): 581-592.
|
| 12 |
Ghofrani HA, Gomberg-Maitland M, Zhao L, et al. Mechanisms and treatment of pulmonary arterial hypertension[J]. Nat Rev Cardiol, 2025, 22(2): 105-120.
|
| 13 |
Stearman RS, Bui QM, Speyer G, et al. Systems analysis of the human pulmonary arterial hypertension lung transcriptome[J]. Am J Respir Cell Mol Biol, 2019, 60(6): 637-649.
|
| 14 |
Cheadle C, Berger AE, Mathai SC, et al. Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients[J]. PLoS One, 2012, 7(4): e34951.
|
| 15 |
Saygin D, Tabib T, Bittar HET, et al. Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension[J]. Pulm Circ, 2020, 10(1): 1-15.
|
| 16 |
张嘉莹,樊勇,张卓莉. 肺动脉高压发病机制中的肺血管重塑[J]. 中华临床免疫和变态反应杂志,2023, 17(1): 50-55.
|
| 17 |
任成山,卞士柱,胡明冬. 肺动脉高压的成因及治疗新理念[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(1): 1-5.
|
| 18 |
中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会,肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,全国肺动脉高压标准化体系建设项目专家组. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021, 101(1): 11-51.
|
| 19 |
Groth A, Vrugt B, Brock M, et al. Inflammatory cytokines in pulmonary hypertension[J]. Respir Res, 2014, 15(1): 47.
|
| 20 |
Xu WJ, Wu Q, He WN, et al . Interleukin-6 and pulmonary hypertension: from physiopathology to therapy[J]. Front Immunol, 2023, 14: 1181987.
|
| 21 |
Pullamsetti SS, Seeger W, Savai R. Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension[J]. J Clin Invest, 2018, 128(5): 1720-1723.
|
| 22 |
Liu SF, Nambiar Veetil N, Li Q, et al. Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening[J]. Front Immunol, 2022, 13: 959209.
|
| 23 |
刘思言,崔狄宇,陈运清. 肺动脉高压相关病理机制的研究进展[J]. 现代医药卫生,2024, 40(2): 288-292.
|
| 24 |
赵十妹,龚娟妮,丁媛,等. 特发性肺动脉高压心肺表型患者的临床及心肺功能特征[J]. 中国循环杂志,2025, 40(8): 770-775.
|
| 25 |
Perros F, Dorfmüller P, Montani D, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2012, 185(3): 311-321.
|
| 26 |
Zhang MQ, Wang CC, Pang XB, et al. Role of macrophages in pulmonary arterial hypertension[J]. Front Immunol, 2023, 14: 1152881.
|
| 27 |
Tobal R, Potjewijd J, van Empel VPM, et al. Vascular remodeling in pulmonary arterial hypertension: The potential involvement of innate and adaptive immunity[J]. Front Med (Lausanne), 2021, 8: 806899.
|
| 28 |
Moratz C, Harrison K, Kehrl JH. Regulation of chemokine-induced lymphocyte migration by RGS proteins[J]. Methods Enzymol, 2004, 389: 15-32.
|
| 29 |
Han SB, Moratz C, Huang NN, et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles[J]. Immunity, 2005, 22(3): 343-354.
|
| 30 |
Feng Z, Zhou J, Liu Y, et al. Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response[J]. Cell Death Differ, 2021, 28(7): 2238-2256.
|
| 31 |
李云飞,翟文倩,韩建阁,等. IL-6在肺动脉高压中的作用研究进展[J]. 吉林医学,2024, 45(7): 1703-1705.
|
| 32 |
陈子宜,孙红燕,康品方,等. 肺动脉高压动物模型构建方法及新型技术研究进展[J]. 实验动物与比较医学,2026, 46(1): 81-93.
|
| 33 |
杜红枝,范瑾,魏晓露,等. 多模态评估肺动脉高压大鼠模型的构建:影像学、实验室与病理学综合研究[J]. 中国实验诊断学,2025, 29(10): 1197-1204.
|
| 34 |
Fan Y, Hao Y, Gao D, et al. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model[J]. Physiol Res, 2021, 70(2): 213-226.
|